These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 33991530)

  • 21. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological functions of ferroportin in the regulation of renal iron recycling and ischemic acute kidney injury.
    Wang X; Zheng X; Zhang J; Zhao S; Wang Z; Wang F; Shang W; Barasch J; Qiu A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1042-F1057. PubMed ID: 29923765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart Ferroportin Protein Content Is Regulated by Heart Iron Concentration and Systemic Hepcidin Expression.
    Berezovsky B; Frýdlová J; Gurieva I; Rogalsky DW; Vokurka M; Krijt J
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.
    Billesbølle CB; Azumaya CM; Kretsch RC; Powers AS; Gonen S; Schneider S; Arvedson T; Dror RO; Cheng Y; Manglik A
    Nature; 2020 Oct; 586(7831):807-811. PubMed ID: 32814342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis.
    Scindia Y; Dey P; Thirunagari A; Liping H; Rosin DL; Floris M; Okusa MD; Swaminathan S
    J Am Soc Nephrol; 2015 Nov; 26(11):2800-14. PubMed ID: 25788528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload.
    Preza GC; Ruchala P; Pinon R; Ramos E; Qiao B; Peralta MA; Sharma S; Waring A; Ganz T; Nemeth E
    J Clin Invest; 2011 Dec; 121(12):4880-8. PubMed ID: 22045566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferroportin-inhibitor salt: patent evaluation WO2018192973.
    Kadam S; Khaitan M; Banerjee P; Mandhare A
    Expert Opin Ther Pat; 2021 Jul; 31(7):585-595. PubMed ID: 33975503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B.
    Yamashita T; Morotomi N; Sohda T; Hayashi H; Yoshida N; Ochi K; Ohkura I; Karita M; Fujiwara H; Yamashita H; Hattori A; Tatsumi Y
    Clin J Gastroenterol; 2014 Jun; 7(3):260-4. PubMed ID: 26183747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary supplementation with ipriflavone decreases hepatic iron stores in wild type mice.
    Patchen B; Koppe T; Cheng A; Seo YA; Wessling-Resnick M; Fraenkel PG
    Blood Cells Mol Dis; 2016 Sep; 60():36-43. PubMed ID: 27519943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepcidin deficiency undermines bone load-bearing capacity through inducing iron overload.
    Sun L; Guo W; Yin C; Zhang S; Qu G; Hou Y; Rong H; Ji H; Liu S
    Gene; 2014 Jun; 543(1):161-5. PubMed ID: 24561287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of the Hepcidin/Ferroportin Regulatory System Causes Pulmonary Iron Overload and Restrictive Lung Disease.
    Neves J; Leitz D; Kraut S; Brandenberger C; Agrawal R; Weissmann N; Mühlfeld C; Mall MA; Altamura S; Muckenthaler MU
    EBioMedicine; 2017 Jun; 20():230-239. PubMed ID: 28499927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of hepcidin and iron-overload disease.
    Lee PL; Beutler E
    Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells.
    Lunova M; Schwarz P; Nuraldeen R; Levada K; Kuscuoglu D; Stützle M; Vujić Spasić M; Haybaeck J; Ruchala P; Jirsa M; Deschemin JC; Vaulont S; Trautwein C; Strnad P
    J Pathol; 2017 Jan; 241(1):104-114. PubMed ID: 27741349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UBA6 and NDFIP1 regulate the degradation of ferroportin.
    Traeger L; Wiegand SB; Sauer AJ; Corman BHP; Peneyra KM; Wunderer F; Fischbach A; Bagchi A; Malhotra R; Zapol WM; Bloch DB
    Haematologica; 2022 Feb; 107(2):478-488. PubMed ID: 34320783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
    Wallace DF; McDonald CJ; Ostini L; Iser D; Tuckfield A; Subramaniam VN
    Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Influence of Hyperlipidemia on Endothelial Function of FPN1 Tek-Cre Mice and the Intervention Effect of Tetramethylpyrazine.
    Sun MY; Zhang M; Chen SL; Zhang SP; Guo CY; Wang JS; Liu X; Miao Y; Yin HJ
    Cell Physiol Biochem; 2018; 47(1):119-128. PubMed ID: 29763925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development.
    Porter J; Taher A; Viprakasit V; Kattamis A; Coates TD; Garbowski M; Dürrenberger F; Manolova V; Richard F; Cappellini MD
    Expert Rev Hematol; 2021 Jul; 14(7):633-644. PubMed ID: 34324404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The iron chaperone poly(rC)-binding protein 1 regulates iron efflux through intestinal ferroportin in mice.
    Wang Y; Protchenko O; Huber KD; Shakoury-Elizeh M; Ghosh MC; Philpott CC
    Blood; 2023 Nov; 142(19):1658-1671. PubMed ID: 37624904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting PKCα alleviates iron overload in diabetes and hemochromatosis through the inhibition of ferroportin.
    Banerjee S; Lu S; Jain A; Wang I; Tao H; Srinivasan S; Nemeth E; He P
    Blood; 2024 Sep; 144(13):1433-1444. PubMed ID: 38861671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepcidin in iron overload disorders.
    Papanikolaou G; Tzilianos M; Christakis JI; Bogdanos D; Tsimirika K; MacFarlane J; Goldberg YP; Sakellaropoulos N; Ganz T; Nemeth E
    Blood; 2005 May; 105(10):4103-5. PubMed ID: 15671438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.